Interestingly, the achieved KEGG pathway results revealed that “pathway of prostate cancer” including well-known tumor suppressor NKX3–1 was also predicted to be involved in PCa (Fig. 6f). This evidence concerns the gene NKX3-1 and prostate carcinoma.